Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome
Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome作者机构:Institute of BiomedicinePharmacologyUniversity of Helsinki Valio LtdResearch Centre Tampere Health Centre and Department of MedicineTampere City Hospital Department of PathologyJorvi HospitalHelsinki University Central Hospital VTT Technical Research Centre of Finland Foundation for Nutrition Research
出 版 物:《World Journal of Gastroenterology》 (世界胃肠病学杂志(英文版))
年 卷 期:2009年第15卷第48期
页 面:6068-6074页
核心收录:
学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
基 金:Supported by Valio Ltd and the Finnish Funding Agency for Technology and Innovation(TEKES) the preparation of this manuscript was funded in part by the Academy of Finland
主 题:Functional gastrointestinal diseases Irritable bowel syndrome Histopathology
摘 要:AIM: To investigate the pathophysiology of irritable bowel syndrome (IBS) by comparing the global mucosal metabolic profiles of IBS patients with those of healthy controls. METHODS: Fifteen IBS patients fulfilling the Rome II criteria, and nine healthy volunteers were included in the study. A combined lipidomics (UPLC/MS) and metabolomics (GC × GC-TOF) approach was used to achieve global metabolic profiles of mucosal biopsies from the ascending colon. RESULTS: Overall, lipid levels were elevated in patients with IBS. The most significant upregulation was seen for pro-inflammatory lysophosphatidylcholines. Other lipid groups that were significantly upregulated in IBS patients were lipotoxic ceramides, glycosphingolipids, and di-and triacylglycerols. Among the meo tabolites, the cyclic ester 2(3H)-furanone was almost 14-fold upregulated in IBS patients compared to healthy subjects (P = 0.03). CONCLUSION: IBS mucosa is characterised by a distinct pro-inflammatory and lipotoxic metabolic profile. Especially, there was an increase in several lipid species such as lysophospholipids and ceramides.